Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis

NCT: NCT06598319 · RECRUITING

NCT IDNCT06598319
StatusRECRUITING
Start Date2024-11-15
Completion2026-12

Brief Summary

Evaluation of safety, effectiveness and tolerability of the Aventix Medical Device used for the treatment of chronic rhinitis

Frequently Asked Questions

What is Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis?

Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis is a clinical trial registered under NCT06598319. Current status: RECRUITING.

What is the status of NCT06598319?

The current status of NCT06598319 (Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis) is: RECRUITING.

When did Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis start?

Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis started on 2024-11-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑